BeiGene ndert am 2. Januar Nasdaq Tickersymbol in ONC auf der 43. Annual J.P. Morgan Healthcare Conference prsent
BGNE Stock | USD 184.68 3.06 1.68% |
About 65% of all BeiGene's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding BeiGene suggests that some traders are interested. The current market sentiment, together with BeiGene's historical and current headlines, can help investors time the market. In addition, many technical investors use BeiGene stock news signals to limit their universe of possible portfolio assets.
BeiGene |
BeiGene, Ltd. , ein globales Unternehmen fr Onkologie, wird seinen Namen in BeOne Medicines Ltd. umwandeln. E
Read at businesswire.com
BeiGene Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards BeiGene can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
BeiGene Fundamental Analysis
We analyze BeiGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeiGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeiGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
BeiGene is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
BeiGene Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BeiGene stock to make a market-neutral strategy. Peer analysis of BeiGene could also be used in its relative valuation, which is a method of valuing BeiGene by comparing valuation metrics with similar companies.
Peers
BeiGene Related Equities
TVTX | Travere Therapeutics | 3.79 | ||||
BPMC | Blueprint Medicines | 1.28 | ||||
KRYS | Krystal Biotech | 1.24 | ||||
AKRO | Akero Therapeutics | 1.16 | ||||
IMAB | I Mab | 1.11 | ||||
ASND | Ascendis Pharma | 1.10 | ||||
BMRN | Biomarin Pharmaceutical | 0.59 | ||||
LEGN | Legend Biotech | 0.06 | ||||
PCVX | Vaxcyte | 0.15 | ||||
INCY | Incyte | 0.50 | ||||
ARWR | Arrowhead Pharmaceuticals | 0.51 | ||||
IONS | Ionis Pharmaceuticals | 0.55 | ||||
APLS | Apellis Pharmaceuticals | 1.08 | ||||
IMVT | Immunovant | 1.34 |
Complementary Tools for BeiGene Stock analysis
When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |